NCT04320264

Brief Summary

The focus of this proposal is on overweight (25\>BMI\<30 kg/m2) subjects, as these individuals exhibit a high risk of becoming obese and/or developing metabolic diseases. We hypothesize that in some overweight individuals there is a "metabolic program" in skeletal muscle which predisposes them to the development of obesity. Findings may lead to clinical screening tools for determining risk for obesity in non-obese individuals and targeting this group for prevention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

March 3, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 7, 2025

Status Verified

August 1, 2025

Enrollment Period

5.8 years

First QC Date

September 3, 2019

Last Update Submit

August 4, 2025

Conditions

Keywords

Metabolic InflexibilityObesityAnaerobic glycolysis

Outcome Measures

Primary Outcomes (6)

  • Carbohydrate/fat oxidation (RER) in the fasting condition.

    RER will be measured from indirect calorimetry

    Years 1-5

  • Muscle oxygen consumption (substrate oxidation) in the fasting condition.

    Muscle oxygen consumption will be measured by near-infrared spectroscopy (NIRS)

    Years 1-5

  • Muscle lactate release in the fasting condition.

    Muscle lactate release will be measured by microdialysis

    Years 1-5

  • Change in Carbohydrate/fat oxidation (RER) in response to glucose + insulin (metabolic flexibility)

    Indirect calorimetry during glucose clamp

    Years 1-5

  • Change in muscle fat oxidation in response to high fat feeding (metabolic flexibility).

    Oxidation of fatty acid in muscle homogenate.

    Years 1-5

  • Change in muscle oxygen consumption (substrate oxidation) in response to high fat feeding (metabolic flexibility).

    Oxygen consumption measured by near-infrared spectroscopy (NIRS)

    Years 1-5

Secondary Outcomes (2)

  • Insulin sensitivity (clamp M value).

    Years 1-5

  • Endogenous glucose production in the fasting condition.

    Years 1-5

Study Arms (3)

Low oxidizers/high lactate

Individuals with low aerobic oxidation

High oxidizers/low lactate

Individuals with high aerobic oxidation

Obese

Severely obese scheduled for surgery

Procedure: Weight loss surgery

Interventions

Severely obese women (BMI \>40) undergo sleeve gastrectomy

Obese

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

High oxidizers Low oxidizers Obese

You may qualify if:

  • years old
  • BMI of 25 - 30 kg/m2
  • BMI \> 40kg/m2
  • Lactate levels in top and lower 25%

You may not qualify if:

  • Pregnant women
  • Mentally disabled
  • Prisoners
  • Smokers
  • Subjects with heart disease
  • Type 1 and 2 diabetes
  • Endocrine disease
  • Hypertension
  • Musculoskeletal disease
  • Peripheral occlusion
  • Hepatic disease
  • Have had weight fluctuations exceeding + 3% in the previous 12 months
  • On medications which alter carbohydrate metabolism will not be studied

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East Carolina University

Greenville, North Carolina, 27834, United States

RECRUITING

Related Publications (5)

  • Ryan TE, Brophy P, Lin CT, Hickner RC, Neufer PD. Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements. J Physiol. 2014 Aug 1;592(15):3231-41. doi: 10.1113/jphysiol.2014.274456. Epub 2014 Jun 20.

    PMID: 24951618BACKGROUND
  • Camisa C, Rossana C. Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin. Arch Dermatol. 1984 Oct;120(10):1323-8.

    PMID: 6237617BACKGROUND
  • Craglietto T, Giarelli L, Paolini A. [Comparative study of the DNA content of human female breast adenocarcinomas and of their recurrences. (Histo-spectrophotometric findings)]. Riv Anat Patol Oncol. 1964 Nov-Dec;26(5):694-706. No abstract available. Italian.

    PMID: 5866193BACKGROUND
  • Ciresa M, Gabl F, Knapp E. [Acid-base equilibrium]. Wien Klin Wochenschr. 1970 Jan 2;82(1):11-2. No abstract available. German.

    PMID: 5513193BACKGROUND
  • Iwamasa J, Tajima C, Matsuura K, Okamura H. [Role of progesterone in the ovulatory process of PMSG/hCG treated immature female rats]. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Oct;41(10):1551-6. Japanese.

    PMID: 2584808BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood and tissue samples without analysis of DNA

MeSH Terms

Conditions

Obesity

Interventions

Bariatric Surgery

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Study Officials

  • Joseph Houmard, PhD

    East Carolina University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Terry Jones, PhD

CONTACT

Nicholas Broskey, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2019

First Posted

March 24, 2020

Study Start

March 3, 2020

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

August 7, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations